Alignment Healthcare president grants RSUs, sells shares

Alignment Healthcare, Inc. president Dawn Christine Maroney reported mixed insider activity in Common Stock.

Rhea-AI Filing Summary

Alignment Healthcare, Inc. president Dawn Christine Maroney reported mixed insider activity in Common Stock. On March 13, 2026, she received 161,860 restricted stock units, each representing one share, which will vest in roughly equal thirds on each of the first three anniversaries of the grant date, subject to continued service.

On March 16, 2026, she completed an open-market sale of 30,000 shares at a weighted-average price of $17.4809 per share, with individual sale prices ranging from $17.12 to $17.60. Following the sale, she directly held 1,095,562 shares of Common Stock. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on May 22, 2025.

Insider Trade Summary 10b5-1

Net Seller: 30,000 shares

Net Sell 2 txns

Insider Maroney Dawn Christine

Role President

Sold 30,000 shs ($524K)

Type	Security	Shares	Price	Value
Sale	Common Stock	30,000	$17.4809	$524K
Grant/Award	Common Stock	161,860	$0.00	$0.00

Holdings After Transaction: Common Stock — 1,095,562 shares (Direct)

Footnotes (3)

1. F1. Represents 161,860 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.
2. F2. Date of Rule 10b5-1 plan adoption: 05/22/2025
3. F3. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.12 to $17.60. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Alignment Healthcare (ALHC) president Dawn Maroney report?

Dawn Maroney reported two transactions: a grant of 161,860 restricted stock units on March 13, 2026, and an open-market sale of 30,000 common shares on March 16, 2026, executed under a pre-arranged Rule 10b5-1 trading plan.

How many Alignment Healthcare (ALHC) shares did the president sell and at what price?

The president sold 30,000 common shares on March 16, 2026, at a weighted-average price of $17.4809 per share, with individual transaction prices ranging from $17.12 to $17.60, as disclosed in the Form 4 filing footnotes.

What is the structure of the 161,860 RSU grant to Alignment Healthcare (ALHC) president?

The grant consists of 161,860 restricted stock units, each representing one share of common stock. These RSUs vest in approximately one-third installments on each of the first three anniversaries of the grant date, conditioned on her continued service with Alignment Healthcare.

How many Alignment Healthcare (ALHC) shares does the president hold after these transactions?

After the reported transactions, Dawn Maroney directly holds 1,095,562 shares of Alignment Healthcare common stock. This figure reflects her position following the March 16, 2026 open-market sale of 30,000 shares disclosed in the Form 4 filing.

Was the Alignment Healthcare (ALHC) insider stock sale made under a Rule 10b5-1 plan?

Yes, the 30,000-share sale on March 16, 2026 was executed pursuant to a Rule 10b5-1 trading plan. The footnotes state the plan was adopted on May 22, 2025, indicating the sale was pre-arranged rather than timed discretionarily.

Does the RSU grant to Alignment Healthcare (ALHC) president involve an immediate cash payment?

The 161,860 RSUs were granted at a price of $0.0000 per unit, indicating no cash payment by the president at grant. Each restricted stock unit represents the right to receive one share upon vesting, subject to continued employment conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 05:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maroney Dawn Christine

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		A		161,860(1)	A	$0	1,125,562	D
Common Stock	03/16/2026		S(2)		30,000	D	$17.4809(3)	1,095,562	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 161,860 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

2. Date of Rule 10b5-1 plan adoption: 05/22/2025

3. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.12 to $17.60. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Dawn C. Maroney	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.